HYTN Shareholders Approve Spin Out of Peptide Development Labs Inc.

VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) (“HYTN”) and Peptide Development Labs Inc. (“PDL”) are pleased to announce the results of HYTN’s Annual General and Special Meeting of shareholders (“HYTN Shareholders”) held today in Vancouver (the “Meeting”). At the Meeting, HYTN Shareholders voted 100% in favour of approving the spin-out of PDL.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.